Back to BlackRock, Inc. BlackRock, Inc.

ZBIOZBIO
6 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ZENAS BIOPHARMA INC

BlackRock, Inc. holds 2M shares of ZBIO (ZENAS BIOPHARMA INC), worth $39.8M as of 2026-Q1. The position was increased (+15.3% shares). ZBIO represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$39.8M

Current Shares

2M

Total Value Change

+$31.6M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2M
+15.3%
$39.8M0.0%$25.18
33
2025-Q4
Increased
1.8M
+43.9%
$64.2M0.0%$36.58
40
2025-Q3
Increased
1.2M
+12.1%
$27.3M0.0%$20.57
32
2025-Q2
Increased
1.1M
+8.0%
$10.6M0.0%$9.58
30
2025-Q1
Increased
1M
+0.8%
$8M0.0%$8.17
28
2024-Q4
New
1M
-
$8.2M0.0%$8.99
38

Other major holders of ZBIO: FMR LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used